Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6554 USD | +5.29% | +2.57% | -51.45% |
Financials (USD)
Sales 2024 * | 3K | Sales 2025 * | 2.5M | Capitalization | 23.52M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -77M | EV / Sales 2024 * | 7,839 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 9.4 x |
P/E ratio 2024 * |
-0.45
x | P/E ratio 2025 * |
-0.52
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Biora Therapeutics, Inc.
1 day | +5.29% | ||
1 week | +2.57% | ||
1 month | -40.42% | ||
3 months | -30.28% | ||
6 months | -66.30% | ||
Current year | -51.45% |
Managers | Title | Age | Since |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 19-04-30 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 14-05-31 | |
Jeffrey Alter
CHM | Chairman | 61 | 18-12-31 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.6554 | +5.29% | 254,907 |
24-04-29 | 0.6225 | -0.83% | 128,041 |
24-04-26 | 0.6277 | +3.41% | 133,686 |
24-04-25 | 0.607 | -2.08% | 151,521 |
24-04-24 | 0.6199 | -2.99% | 184,411 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.45% | 23.52M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.23% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- BIOR Stock